China Ag Rapid Test Kit manufacturer
Henan Lantian Medical Supplies Co.,Ltd.
The company always adheres to the core concept of "fast and accurate, live up to life", and is committed to providing excellent products and services for the society and contributing to the
5
Home > Products > Ag Rapid Test Kit >

Combined CTnI Myo CK-MB Rapid Test For Outpatient Emergency Clinical

Combined CTnI Myo CK-MB Rapid Test For Outpatient Emergency Clinical

Brand Name Combined CTnI Myo CK-MB Rapid Test For Outpatient Emergency Clinical
Model Number cTnl/MYO/CK-MB
Certification CE
Place of Origin Henan
Minimum Order Quantity To be negotiated
Price To be negotiated
Supply Ability 10000 Kit/Kit per Day
Delivery Time To be negotiated
Packaging Details Kit
Sample type Whole Blood,Serum,Plasma
Mixing requirements Mix well
Sample size after dilution 60μL
Reaction time 15min
Detection range cTnl:0.1~50ng/mL;MYO:10~200ng/mL;CK-MB:0.8~100ng/mL
Application Department Outpatient, emergency
Detailed Product Description

Combined CTnI Myo CK-MB Rapid Test For Outpatient Emergency Clinical

 

CTnI/MYO/CK-MB Overview


The isoenzyme troponin I/myoglobin/creatine kinase (cTnI/Myo/CK-MB) includes the following three indicators: The combined detection of troponin I (cTnI), myoglobin (Myo) and creatine kinase isoenzyme (CK-MB) is of great importance for the Early diagnosis of acute myocardial diseases such as AMI

 

American Society for Clinical Biochemistry ( NACB ) Practice Guide

Signs of myocardial necrosis should be detected in all patients with ACS
Troponin is a key marker in the diagnosis of myocardial infarction
Myoglobin binding specific markers of myocardial necrosis (eg, cTnI/CK-MB) may help clear or diagnose myocardial infarction more quickly.

 

 MYOCK-MBcTnI
molecular weight17.8KD86KD22.5KD
Rise time1-2h4-6h3-6h
Peak time6-9h24h12-16h
recovery time18-30h2-3d4-10d
Clinical value

1. The most important AMI map was released in the first stage
2. Re-diagnose America and the best indication to evaluate the effect of re-treatment

1. Font size or re-launch
2. The most valuable mark of the highest non-ST part of MI

1. Preferential signs for diagnosing AMI
2. Judge the size of the gap and the risk strategy

 

 

cTnI/MYO/CK-MB Performance Index


Detection rangesample sizeSample typeTest time
cTnIMYOCK-MB60μlWhole blood / serum / plasma15min
0.1~50ng/mL10~200ng/mL0.8~100ng/mL

 

 

 

CTnI/MYO/CK-MB Clinical Significance


  • This is for the initial and strategic diagnosis of corneal syndrome risk
  • Defining the area of myocardial infarction
  • Different diagnosis of different causes of chest pain
  • Beware of myocardial injury for a variety of reasons
  • Evaluation of clinical evidence of some medical drugs

 

Possibility of outcome 
cTnICK-MBMYOClinical possibility

+

++Myocardial infarction / myocardial injury can basically be diagnosed and the time of onset is 12-24 hours.
++-It can basically be diagnosed as a myocardial infarction injury / myocardial infarction injury, and the detection time is more than one day that has passed during the myocardial identification window.
+--Myocardial damage occurs for a few days and should be rechecked in a few hours.
+-+In patients with hepatic myocardial injury, symptoms may last for more than three days, and in patients with re-injury or necrotic areas due to blood clots.
-++In early myocardial ischemia, liver myocardial injury following monitoring of CTNI in 4-8 hours is recommended.

-

-+It is recommended to check CTNN in 4-8 hours.
The reserves can be caused by other diseases such as creative work, musculoskeletal injuries, and liver and kidney disease.
-+-For minor myocardial injury, we recommend CT monitoring in 4-8 hours.
It may not be myocardial injury and the test time was through my window.

-

--The possibility of ischemic myocardial injury is generally ruled out. When in doubt, it is recommended to check every two to four hours.

 

 

 

Application Department


Emergency outpatient departments, Cardiovascular Examination Centers, ICUs and Chest Pain Centers

 

 

CTnI/MYO/CK-MB Clinical Comparison


 

 

Company profile


Zhongxiu Science And Technology Co.,Ltd., is a high-tech enterprise engaged in the research and development, production and operation of in vitro diagnostic products. The in vitro diagnostic products developed by the company cover POCT series, microbial series, biochemical series and immune series reagents and supporting instruments.
The company has always adhered to the core concept of "fast and accurate, living up to life", committed to providing society with excellent products and services, and contributing to the cause of human health.

 

 

 

 

Product Tags: CTnI Myo CK-MB Rapid Test Kit   60μL cTnI Myo CK-MB Test Kit  
Related Products
Email to this supplier
 
From:
Enter your Email please.
To: Henan Lantian Medical Supplies Co.,Ltd.
Subject:
Message:
Characters Remaining: (80/3000)